February 2012 www.citizen.org Regulation of medical devices—a $350 billion industry that includes such products as heart and brain stents, artificial hips and implantable defibrillators—is at a crossroads. With a major reauthorization bill up for debate, members of Congress already have introduced 14 bills that aim to accelerate devices’ path to the market, often by weakening measures intended to ensure patient safety. Read more
- ‘Bag of Pills’: Is It Necessary? Fewer medications is an achievable goal
- Now There’s Proof: Docs Who Get Company Cash Tend to Prescribe More Brand-Name Meds
- Let’s involve Connecticut patients in reducing medical errors
- Want to know about medical mistakes? Talk to the parents.
- Number of hospital accidents not getting any better